← SynDRA
MEBENDAZOLE
SynDRA canonical compound SYN0001387 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | TUBA1A | TUBB | TUBB4B |
|---|
| Mechanism of action | tubulin polymerization inhibitor |
|---|
| Indication | ascariasis | hookworm | pinworm | whipworm |
|---|
| Disease area | infectious disease |
|---|
All known targets
- ABL1
- CDPK1
- KDR
- TUBA1A
- TUBB
- TUBB4B
Mechanisms of action (all sources)
- tubulin polymerization inhibitor
Drug classes
- Anthelmintic
- Anthelmintics
- Anti-Infective Agents
- Antimitotic Agents
- Antinematodal Agents
- Antiparasitic Agents
- Tubulin Modulators
ATC classes
- P02C · ANTINEMATODAL AGENTS
Cross-references
Synonyms
- vermox
- Mebendazol
- Mebendazolum
- Ovitelmin
- Pantelmin
- Vermicidin
- Zhihuanqing
- NSC-184849
- R 17,635
- R-17635
- Emverm
- Mebenvet
- Telmintic
- Vermox
- Mebendazole polymorph c
- Bantenol
- Banworm
- Besantin
- Lomper
- MBDZ
- Madicure
- Mebendan
- Mebenoazole
- Mebex
- Mebutar
- Noverme
- Sqworm
- Sufil
- Surfont
- Telmin
- Vermicol
- Vermidil
- Vermin
- Vermirax
- Verpanyl
- Versid
- Wormkuur
- Abello Farmacia Brand of Mebendazole
Reported adverse events
- Neutropenia
- Alopecia
- Angioedema
- Dizziness
- Flatulence
- Hepatitis
- Hypersensitivity
- Nausea
- Urticaria
- Vomiting
- Agranulocytosis
- Rash
Look up MEBENDAZOLE in the interactive SynDRA portal →